Citations

Showing 10 of 108152 citations.

A Case of Acute Pulmonary Embolus after mRNA SARS-CoV-2 Immunization
Wiest, Nathaniel E. , Johns, Gretchen S., Edwards, Eric, Edwards, Eric

Mayo Clinic

Vaccines | August 15, 2021 | Volume: 9 | Issue: 8 | Pages: 903

10.3390/vaccines9080903 | PMID 34452028 Get It

Vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), is a critical strategy to overcome the COVID-19 pandemic. Multiple SARS-CoV-2 vaccines have been developed in a rapid timeframe to combat the pandemic. While generally safe and effective, rare cases of venous thromboembolism (VTE) have been reported after two adenovirus-based vaccines, the AstraZeneca ChAdOx1 nCoV-19 vaccine and the Janssen Ad.26.COV2.S vaccine, as well as after the Pfizer-BioNTech BNT162b2 mRNA vaccine. Here, we present the case of a patient who developed acute pulmonary emboli (PE) shortly after his second dose of the Moderna mRNA-1273 SARS-CoV-2 vaccine. We report the results of an extensive thrombophilia workup that was normal except for the identification of positive lupus anticoagulant (LA) signals. It is our goal to contribute to the body of knowledge regarding SARS-CoV-2 vaccines and encourage vaccine adverse event reporting so that clinicians can have a full appreciation and awareness of the possible adverse events related to these critical vaccines.
Evaluating Markers of Immune Tolerance and Angiogenesis in Maternal Blood for an Association with Risk of Pregnancy Loss
Wyatt, Michelle A. , Baumgarten, Sarah C., Weaver, Amy L. , Oort, Chelsie C. Van, Fedyshyn, Bohdana , Ruano, Rodrigo , Shenoy, Chandra C. , Enninga, Elizabeth Ann L. , Van Oort, Chelsie C, Ruano, Rodrigo , Enninga, Elizabeth Ann L

Mayo Clinic

Journal of Clinical Medicine | August 15, 2021 | Volume: 10 | Issue: 16 | Pages: 3579

10.3390/jcm10163579 | PMID 34441875 Get It

Pregnancy loss affects approximately 20% of couples. The lack of a clear cause complicates half of all miscarriages. Early evidence indicates the maternal immune system and angiogenesis regulation are both key players in implantation success or failure. Therefore, this prospective study recruited women in the first trimester with known viable intrauterine pregnancy and measured blood levels of immune tolerance proteins galectin-9 (Gal-9) and interleukin (IL)-4, and angiogenesis proteins (vascular endothelial growth factors (VEGF) A, C, and D) between 5 and 9 weeks gestation. Plasma concentrations were compared between groups defined based on (a) pregnancy outcome and (b) maternal history of miscarriage, respectively. In total, 56 women were recruited with 10 experiencing a miscarriage or pregnancy loss in the 2nd or 3rd trimester and 11 having a maternal history or miscarriage. VEGF-C was significantly lower among women with a miscarriage or pregnancy loss. Gal-9 and VEGF-A concentrations were decreased in women with a prior miscarriage. Identification of early changes in maternal immune and angiogenic factors during pregnancy may be a tool to improve patient counseling on pregnancy loss risk and future interventions to reduce miscarriage in a subset of women.
Spectrum of hematological malignancies, clonal evolution and outcomes in 144 Mayo Clinic patients with germline predisposition syndromes
Martin, Emma C. St. , Mangaonkar, Abhishek A. , Khan, Shakila P. , Kohorst, Mira A. , Joshi, Avni Y. , Olteanu, Horatiu , Moyer, Ann M. , Al‐Kali, Aref , Tefferi, Ayalew , Chen, Dong , Wudhikarn, Kitsada , Viswanatha, David S., He, Rong , Nguyen, Phuong L., Oliveira, Jennifer L. , Gangat, Naseema , Patnaik, Mrinal M. , Herrick, Jennifer L. , St Martin, Emma C , Mangaonkar, Abhishek A. , Tefferi, Ayalew , Chen, Dong , Viswanatha, David, He, Rong , Patnaik, Mrinal , Ferrer, Alejandro , Hogan, William J. , Go, Ronald S. , Ketterling, Rhett P. , Lasho, Terra L.

Mayo Clinic

American Journal of Hematology | August 14, 2021 | Volume: 96 | Issue: 11 | Pages: 1450-1460

10.1002/ajh.26321 | PMID 34390506 Get It

AbstractGermline predisposition syndromes (GPS) result from constitutional aberrations in tumor suppressive and homeostatic genes, increasing risk for neoplasia in affected kindred. In this study, we present clinical and genomic data on 144 Mayo Clinic patients with GPS; 59 evaluated prospectively using an algorithm‐based diagnostic approach in the setting of a dedicated GPS/ inherited bone marrow failure syndrome (IBMFS) clinic. Seventy‐two (50%) patients had IBMFS (telomere biology disorders‐32,Fanconi anemia‐18, Diamond Blackfan Anemia – 11, congenital neutropenia–5, Schwachman‐Diamond Syndrome‐5 and Bloom Syndrome‐1), 27 (19%) had GPS with antecedent thrombocytopenia (RUNX1‐FPD‐15, ANKRD26‐6, ETV6‐2, GATA1‐1, MPL‐3), 28 (19%) had GPS without antecedent thrombocytopenia (GATA2 haploinsufficiency‐16, DDX41‐10, CBL‐1 and CEBPA‐1) and 17 (12%) had general cancer predisposition syndromes (ataxia telangiectasia‐7, heterozygous ATM variants‐3, CHEK2‐2, TP53‐2, CDK2NA‐1, NF1‐1 and Nijmegen Breakage Syndrome‐1). Homozygous and heterozygous ATM pathogenic variants were exclusively associated with lymphoproliferative disorders (LPD), while DDX41 GPS was associated with LPD and myeloid neoplasms. The use of somatic NGS‐testing identified clonal evolution in GPS patients, with ASXL1, RAS pathway genes, SRSF2 and TET2 being most frequently mutated. Fifty‐two (91%) of 59 prospectively identified GPS patients had a change in their management approach, including additional GPS‐related screening in 42 (71%), referral for allogenic HSCT workup and screening of related donors in 16 (27%), medication initiation and selection of specific conditioning regimens in 14 (24%), and genetic counseling with specific intent of fertility preservation and preconceptual counseling in 10 (17%) patients; highlighting the importance of dedicated GPS screening, detection and management programs for patients with hematological neoplasms.
Hyponatremia induced Brugada syndrome mimicking ST segment elevation myocardial infarction
Senthong, Vichai , Senthong, Vichai , Rattanawong, Pattara

Mayo Clinic

Journal of Arrhythmia | August 14, 2021 | Volume: 37 | Issue: 5 | Pages: 1377-1379

10.1002/joa3.12617 | PMID 34621444 Get It

Psycho‐oncology in the Arab world: The time is now
Hayek, Samer El , Dakroub, Ali , Beaini, Hadi , Salem, Hiba, Saliba, Antoine N. , Ehlers, Shawna L. , Saliba, Antoine N. , El Hayek, Samer , Saliba, Antoine N , Saliba, Antoine N , Bizri, Maya , Taher, Alì

Mayo Clinic

Psycho-Oncology | August 14, 2021 | Volume: 31 | Issue: 1 | Pages: 148-151

10.1002/pon.5778 | PMID 34390087 Get It

Safety of the transradial approach to carotid stenting
Erben, Young , Heck, Donald , Shawl, Fayaz A., Mayorga‐Carlin, Minerva , Brott, Thomas G. , Lal, Brajesh K. , Brott, Thomas G , Meschia, James F. , Howard, George , Rosenfield, Kenneth , Sorkin, John David

Mayo Clinic

Catheterization and Cardiovascular Interventions | August 14, 2021 | Volume: 99 | Issue: 3 | Pages: 814-821

10.1002/ccd.29912 | PMID 34390107 Get It

Abstract Background The multicenter prospective CREST‐2 Registry (C2R) provides recent experience in performing carotid artery stenting (CAS) for interventionists to ensure safe performance of CAS. Objective To determine the periprocedural safety of CAS performed using a transradial approach relative to CAS performed using a transfemoral approach. Methods Patients with ≥70% asymptomatic and ≥50% symptomatic carotid stenosis, ≤80 years of age and at standard or high risk for carotid endarterectomy (CEA) are eligible for the C2R. The primary endpoint was a composite of severe access‐related complications. Comparisons were made using propensity‐score matched logistic regression. Results The mean age of the cohort was 67.6 ± 8.2 years and 1906 (35.1%) were female. Indications for CAS included 4063 (74.9%) for primary atherosclerosis. A total of 2868 (52.8%) cases underwent CAS for asymptomatic disease. Transradial access was used in 213 (3.9%) patients. The transradial cohort had lower use of general anesthesia (1.5% vs. 6.3%, p = 0.007) and higher use of distal embolic protection (96.7% vs. 89.4%, p = 0.0004). There were no significant differences between radial and femoral access groups in terms of a composite of major access‐related complications (0% vs. 1.1%) or a composite of periprocedural stroke or death (3.3% vs. 2.4%; OR = 1.4 [confidence intervals 0.6, 3.1]; p = 0.42). Conclusion We found no significant differences in rates of major access‐related complications or periprocedural stroke or death with CAS performed using transradial compared to transfemoral access. Our results support incorporation of the transradial approach to clinical trials comparing CAS to other revascularization techniques.
Three Cases of Emergency Department Medical Malpractice Involving “Consultations”: How Is Liability Legally Determined?
Aldalati, Alaa, Bellamkonda, Venkatesh R. , Finch, Alexander S. , Moore, Gregory P. , Moore, Gregory

Mayo Clinic

Clinical Practice and Cases in Emergency Medicine | August 14, 2021 | Volume: 5 | Issue: 3 | Pages: 283-288

10.5811/cpcem.2021.7.52680 | PMID 34437032 Get It

This article presents three successfully litigated medical malpractice cases involving emergency physicians and consultants. We discuss the respective case medical diagnoses, as well as established legal principles that determine in a court proceeding which provider will be liable. Specifically, we explain the legal principles of “patient physician relationship” and “affirmative act.”
Pimavanserin
Ali, Farwa

Mayo Clinic

Neurology | August 13, 2021 | Volume: 97 | Issue: 13 | Pages: 613-614

10.1212/wnl.0000000000012656 | PMID 34389650 Get It

Back to Basics: When to Order (and When Not to Order) Serologic Testing for the Diagnosis of Infectious Diseases
Theel, Elitza S.

Mayo Clinic

Clinical Chemistry | August 13, 2021 | Volume: 68 | Issue: 1 | Pages: 36-39

10.1093/clinchem/hvab166 | PMID 34969100 Get It